Using Color Doppler US Artifact to Identify Tumor Markers
NCT06166173 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 60
Last updated 2023-12-12
Summary
Before neoadjuvant chemotherapy (NACT) in cases of locally advanced breast cancer, malignant masses in the breast and biopsy-proven tumor involvement axillary lymph nodes are marked with metallic markers. The primary objective of this marking is to establish the precise localization of the tumor which response to NACT partial or completely. However, selecting the marker with ultrasound (US) proves challenging in many instances. Research studies indicate that patients with occult markers are observed at a frequency of 24%. Some studies propose that the twinkling artifact serves as a reliable method for accurately indicating the localization of certain tumor markers. This artifact is deemed particularly helpful for lesions situated in the axilla or posterior of the breast, which may not be visible with US and are undetectable with mammography.
In the context of Color Doppler examination, the investigators have noted the presence of another color Doppler artifact which can aid in determining marker localization. When the pulse repetition frequency (PRF) is reduced and the color gain is increased, color noise, termed as color confusion or blooming artifact/effect, is observed within the color steer. While this color confusion tends to mask healthy tissues, it has been observed that the tumor marker remains unaffected by the blooming effect. Consequently, this artifact serves to distinctly reveal the borders and localization of the tumor marker.
In some studies, it has been stated that the twinkling artifact, which is a color Doppler artifact and whose mechanism is not fully understood, is a reliable method to accurately indicate the localization of some tumor markers. It has been reported that this artifact will be very helpful, especially in lesions located in the axilla or posterior of the breast, which cannot be seen with US and cannot be detected with mammography .
In Color Doppler examination, we saw that another color Doppler artifact, such as the twinkling artifact, could also be helpful in determining marker localization. When the PRF is reduced and the color gain is increased, color noise, which is selected as color confusion and can be called blooming artifact or blooming effect-like, is observed in all structures within the color steer. While healthy tissues are masked by this color confusion, the tumor marker is protected from the blooming effect. Thus, with this artifact, tumor marker borders and localization are clearly revealed.
Conditions
- Breast Cancer
- Interventional Radiology
- Doppler Ultrasound
Sponsors & Collaborators
-
Istanbul Medeniyet University
lead OTHER
Eligibility
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2023-08-01
- Primary Completion
- 2023-12-31
- Completion
- 2024-01-31
Countries
- Turkey (Türkiye)
Study Locations
More Related Trials
-
Ultrasound and Near Infrared Imaging for Predicting and Monitoring Neoadjuvant Treatment
NCT02891681 ·Status: COMPLETED ·Phase: NA
-
Quantitative Microvasculature Imaging for Breast Cancer Detection and Monitoring
NCT04799535 ·Status: RECRUITING
-
Sentinel Lymph Node Identification in the Axilla of Women With Breast Cancer Using Ultrasound and Iron Injection
NCT02610920 ·Status: WITHDRAWN ·Phase: EARLY_PHASE1
-
Magnetic Marker Localization for Occult Breast Cancer and Target Axillary Dissection in Node-positive Breast Cancer Post-neoadjuvant Chemotherapy
NCT05427071 ·Status: RECRUITING ·Phase: NA
-
Focused Ultrasound and Gemcitabine in Breast Cancer
NCT04796220 ·Status: RECRUITING ·Phase: PHASE1
-
To Detect Cryoimmunologic Response Induced by Early Breast Cancer Ultrasound-guided Cryoablation (ICE-study)
NCT05727813 ·Status: COMPLETED ·Phase: NA
-
Application of Radiomics in Breast Cancer
NCT04483804 ·Status: RECRUITING
-
Preoperative Localisation of the Sentinel Lymph Node in Breast Cancer
NCT01154972 ·Status: COMPLETED ·Phase: NA
-
Academic-Industrial Partnership for Translation of Acoustic Angiography
NCT03544268 ·Status: COMPLETED ·Phase: PHASE4
-
Diagnostic US for Reduction of Benign Breast Biopsies Using US-guided Optical Tomography
NCT03842358 ·Status: COMPLETED ·Phase: NA
-
Using Deep Learning and Radiomics to Diagnose Benign and Malignant Breast Lesions Based on Ultrasound
NCT06069921 ·Status: COMPLETED
-
Three-Dimensional Ultrasound and Spectroscopy as Early Indicators of Breast Cancer Response to Neoadjuvant Treatment
NCT06193122 ·Status: NOT_YET_RECRUITING
-
Safety, Ultrasound Conspicuity, and Migration of Twinkling Markers in Patients With Locally Advanced Breast Cancer
NCT05547347 ·Status: SUSPENDED
-
Ultrasound Imaging and Spectroscopy as Early Indicators of Locally-Advanced Breast Cancer Response
NCT04134780 ·Status: RECRUITING
-
Breast-Specific Gamma Imaging and Locally Advanced Breast Cancer Undergoing Neoadjuvant Chemotherapy
NCT02556684 ·Status: UNKNOWN
-
ARFI, VisR and DDAI Ultrasound for Improving Discrimination of Malignant and Unresponsive Breast Cancer
NCT03785782 ·Status: COMPLETED
-
Role of Ultrasound-Guided Lymph Node Biopsy in Axillary Staging of Breast Cancer.
NCT03681418 ·Status: UNKNOWN ·Phase: NA
-
KVUS at Neoadjuvant CTx of Breast Cancer
NCT03385200 ·Status: UNKNOWN ·Phase: PHASE3
-
Sentinel Lymph Node Biopsy With Hybrid Technique in Breast Cancer
NCT04274946 ·Status: UNKNOWN ·Phase: NA
-
Predict the Risk of Axillary Metastases in Breast Cancer Patients With Axillary Ultrasound
NCT02992769 ·Status: UNKNOWN
-
Immun Checkpoint Washout in Patients With Invasive Ductal Breast Cancer
NCT07003009 ·Status: RECRUITING ·Phase: NA
-
Evaluation of Axillary Lymph Node Metastasis Status of Breast Cancer Based on Pathological Images and Virtual Staining
NCT06486155 ·Status: NOT_YET_RECRUITING
-
Enhanced Ultrasound in Determining Extent of Disease in Women With Primary Breast Cancer
NCT00005058 ·Status: UNKNOWN ·Phase: NA
-
Multiparametric High-resolution Ultrasound of the Breast
NCT03276845 ·Status: COMPLETED ·Phase: NA
-
Photoacoustic Imaging for Characterizing Breast Masses and Breast Tumor Response to Neoadjuvant Chemotherapy
NCT04428528 ·Status: RECRUITING